MRI end-points for clinical trials in ataxias: recommendations from the Ataxia Global Initiative MRI Biomarkers Working Group
Gülin Öz(University of Minnesota), Sarah H. Ying(Massachusetts Eye and Ear Infirmary), Marcin Rylski(Institute of Psychiatry and Neurology), Lidia Sarro(Fondazione IRCCS Istituto Neurologico Carlo Besta), Ettore Accolla(Fribourg Development Agency), Rui Jorge Nobre(University of Coimbra), Marina Grisoli(Fondazione IRCCS Istituto Neurologico Carlo Besta), Caterina Mariotti(Fondazione IRCCS Istituto Neurologico Carlo Besta), Niccolò Fuin(Ixico (United Kingdom)), Saud Alhusaini(Montreal Neurological Institute and Hospital), D Timmann(Essen University Hospital), Christophe Lenglet(University of Minnesota), Norbert Kovács(University of Pecs), Deborah Moreira Rangel(Hospital Geral de Fortaleza), Sirio Cocozza(University of Naples Federico II), Antoine Cossa(Servier (France)), Massimo Pandolfo(McGill University), Eva‐Maria Ratai(Harvard University), Andreas Deistung(University Hospital in Halle), Kąstytis Šeštakauskas(UCB Pharma (Belgium)), Astrid Adarmes‐Gómez(Instituto de Biomedicina de Sevilla), Joan A O'Keefe(Rush University Medical Center), Luiza Makowska(Institute of Psychiatry and Neurology), Kirsten Kapteijns(Radboud University Nijmegen), Magda M. Santana(University of Coimbra), Stefan Gazdzinski(Wojskowy Instytut Medycyny Lotniczej), Monica Ferreira(German Center for Neurodegenerative Diseases), Kathrin Reetz(RWTH Aachen University), Fanny Mochel(Centre National de la Recherche Scientifique), Sylvia Boesch(Innsbruck Medical University), Marcondes C. Franca(Universidade Estadual de Campinas (UNICAMP)), Kevin D’Ostilio(UCB Pharma (Belgium)), Andreas Thieme(Essen University Hospital), Jennifer Faber(University Hospital Bonn), Wolfgang Nachbauer(Innsbruck Medical University), Thiago J. R. Rezende(Universidade Estadual de Campinas (UNICAMP)), James M. Joers(University of Minnesota), Pierre-Gilles Henry(University of Minnesota), Ian H. Harding(QIMR Berghofer Medical Research Institute), Anna Nigri(Fondazione IRCCS Istituto Neurologico Carlo Besta), on behalf of the Ataxia Global Initiative Working Group on MRI Biomarkers, Kirsi M. Kinnunen(Ixico (United Kingdom)), Morteza Heidari(Children's Medical Center), Elisabetta Indelicato(Innsbruck Medical University), Martina Minnerop(Forschungszentrum Jülich), Cherie L. Marvel(Johns Hopkins University), Kyota Bando(National Center of Neurology and Psychiatry)
Cited by 1
Related Papers
The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data
|Brain Imaging and Behavior|2014|884
Structural brain abnormalities in the common epilepsies assessed in a worldwide ENIGMA study
|Brain|2017|546
Genetic risk factors for ischaemic stroke and its subtypes (the METASTROKE Collaboration): a meta-analysis of genome-wide association studies
|The Lancet Neurology|2012|488
Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension
|The Lancet Neurology|2018|345
Novel genetic loci associated with hippocampal volume
|Nature Communications|2017|335